Histone Deacetylase Inhibitors Research

Работ: 13

Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona
Yang He, Yuefei Fang, Meng Zhang +7
СтатьяHistone Deacetylase Inhibitors ResearchActa Pharmaceutica Sinica B2021Цитирований: 4
ABI
Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms
Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4
СтатьяProtein Degradation and InhibitorsBiomolecules2026Цитирований: 2
ABI
Demethyldihydroglycyrin tetraacetate
Shakhnoza S. Azimova, Валентина И. Виноградова
ГлаваHyperglycemia and glycemic control in critically ill and hospitalized patients2012Цитирований: 0
ABI
28-epi-Isocyasterone
Shakhnoza S. Azimova
ГлаваOrganic Chemistry Cycloaddition Reactions2012Цитирований: 0
ABI
Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer
Yonghui Wang, Binfan Chen, Zhidi He +7
СтатьяHistone Deacetylase Inhibitors ResearchNanoscale2021Цитирований: 0
ABI
The Effect of Ecdystene on the Activity of Matrix Metalloproteinases in Experimental Alloxan Diabetes in Rats
D. Tursunov, Rixsi A. Sabirova, М. У. Кульманова +5
СтатьяProtease and Inhibitor MechanismsBioNanoScience2021Цитирований: 0
ABI
A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance
Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali +6
СтатьяColorectal Cancer Treatments and StudiesCell Biochemistry and Function2024Цитирований: 0
ABI
Ubiquitylation in the development of somatic diseases: a mechanism of cellular regulation and a new therapeutic target
Александр Ураков, Anton Tyurin, V. S. Shchekin +4
СтатьяUbiquitin and proteasome pathwaysReviews on Clinical Pharmacology and Drug Therapy2024Цитирований: 0
ABI
AML-489: Combination of Azacitidine and Venetoclax in Patients With Acute Myeloid Leukemia: A Single-Center Experience
Farhodjon Tashtemirov, Z.V. Yunusova, M Islamov +3
СтатьяAcute Myeloid Leukemia ResearchClinical Lymphoma Myeloma & Leukemia2025Цитирований: 0
ABI
Therapeutic innovations: targeting ROS production in AML with natural and synthetic compounds
Mohammed H. Mohammed, Raed Fanoukh Aboqader Al-Aouadi, Subasini Uthirapathy +7
Обзорная статьяHistone Deacetylase Inhibitors ResearchNaunyn-Schmiedeberg s Archives of Pharmacology2025Цитирований: 0
ABI
Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications
Hussein Salim Abed, N. Esanmurodova, Abhinav Kumar +6
Обзорная статьяEpigenetics and DNA MethylationNaunyn-Schmiedeberg s Archives of Pharmacology2025Цитирований: 0
ABI
Epigenetic clocks and biological aging acceleration in early-onset hypertension
Alisher Axrorov, Elvina Midatovna Sharipova, Nodirbek Xamidov +3
СтатьяEpigenetics and DNA MethylationZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
ABI
Epigenetic clocks and biological aging acceleration in early-onset hypertension
Alisher Axrorov, Elvina Midatovna Sharipova, Nodirbek Xamidov +3
СтатьяEpigenetics and DNA MethylationZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
ABI